Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 332

Similar articles for PubMed (Select 22619260)

1.

Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.

Tada T, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Byrne RA, Kastrati A, Kadota K, Iwabuchi M, Shizuta S, Tazaki J, Shiomi H, Abe M, Ehara N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ Cardiovasc Interv. 2012 Jun;5(3):381-91. doi: 10.1161/CIRCINTERVENTIONS.111.967463. Epub 2012 May 22.

2.

Duration of Dual Antiplatelet Therapy After Drug-eluting Stents Implantation: The Jury Is Still Out.

Schulz-Schüpke S, Kastrati A.

Rev Esp Cardiol (Engl Ed). 2015 Jun 25. pii: S1885-5857(15)00187-5. doi: 10.1016/j.rec.2015.03.015. [Epub ahead of print] No abstract available.

PMID:
26118900
3.

The Dual Antiplatelet Therapy Trial after the FDA Update: Noncardiovascular Deaths, Cancer and Optimal Treatment Duration.

Serebruany VL, Cherepanov V, Golukhova EZ, Kim MH.

Cardiology. 2015 Jun 23;132(2):74-80. [Epub ahead of print]

PMID:
26111880
4.

Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Which Regimen and for How Long?

Goudevenos JA, Tselepis AD.

Angiology. 2015 Jun 22. pii: 0003319715591333. [Epub ahead of print] No abstract available.

PMID:
26101369
5.

Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2.

de la Torre Hernández JM, Oteo Domínguez JF, Hernández F, García Camarero T, Abdul-Jawad Altisent O, Rivero Crespo F, Cascón JD, Zavala G, Gimeno F, Arrebola Moreno AL, Andraka L, Gómez Menchero A, Bosa F, Carrillo X, Sánchez Recalde Á, Alfonso F, Pérez de Prado A, López Palop R, Sanchis J, Diarte de Miguel JA, Jiménez Navarro M, Muñoz L, Ramírez Moreno A, Tizón Marcos H; ESTROFA-DAPT and ESTROFA-2 study groups.

Rev Esp Cardiol (Engl Ed). 2015 Jun 11. pii: S1885-5857(15)00145-0. doi: 10.1016/j.rec.2015.01.008. [Epub ahead of print]

PMID:
26072146
6.

Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.

Verdoia M, Schaffer A, Barbieri L, Montalescot G, Collet JP, Colombo A, Suryapranata H, Luca G.

Angiology. 2015 Jun 11. pii: 0003319715586500. [Epub ahead of print]

PMID:
26069031
7.

Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.

Eisen A, Bhatt DL.

Nat Rev Cardiol. 2015 Jun 9. doi: 10.1038/nrcardio.2015.87. [Epub ahead of print] No abstract available.

PMID:
26054831
8.

How long should dual antiplatelet therapy be continued following implantation of drug eluting stents?

Ruparelia N, Chieffo A, Colombo A.

Ann Transl Med. 2015 May;3(Suppl 1):S10. doi: 10.3978/j.issn.2305-5839.2015.02.15. No abstract available.

9.

Optimal duration of dual antiplatelet therapy after drug eluting stent remains unclear.

Mayor S.

BMJ. 2015 May 26;350:h2841. doi: 10.1136/bmj.h2841. No abstract available.

PMID:
26013757
10.

Optimal duration of dual antiplatelet therapy after drug eluting stents: Meta-analysis of randomized trials.

Abo-Salem E, Alsidawi S, Jamali H, Effat M, Helmy T.

Cardiovasc Ther. 2015 May 25. doi: 10.1111/1755-5922.12137. [Epub ahead of print]

PMID:
26010419
11.

Longer Versus Shorter Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis.

Spencer FA, Prasad M, Vandvik PO, Chetan D, Zhou Q, Guyatt G.

Ann Intern Med. 2015 May 26. doi: 10.7326/M15-0083. [Epub ahead of print]

PMID:
26005909
12.

Dual antiplatelet therapy following drug-eluting stent implantation: how long is long enough?

Ruparelia N, Chieffo A.

Expert Rev Cardiovasc Ther. 2015 Jun;13(6):585-7. doi: 10.1586/14779072.2015.1046435. Epub 2015 May 14.

PMID:
25973553
13.

Lichenoid dermatits caused by thienopyridine derivatives.

Galeone M, Scarfì F, Bassi A, Massi D, Difonzo EM, Francalanci S.

G Ital Dermatol Venereol. 2015 May 8. [Epub ahead of print] No abstract available.

PMID:
25952285
14.

Is the Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents the Longer the Better?

Huang QY, Bista M, Yang RQ.

Med Princ Pract. 2015;24:398. doi: 10.1159/000381955. Epub 2015 Apr 22. No abstract available.

PMID:
25924625
15.

Effectiveness of prolonged clopidogrel-based dual antiplatelet therapy after drug-eluting stent implantation : Evidence-based meta-analysis.

Liu C, Liu M, Chen D, Liu H, Jiang Q, Lu J, Zuo L.

Herz. 2015 Apr 25. [Epub ahead of print]

PMID:
25911050
16.

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.

Fiedler KA, Maeng M, Mehilli J, Schulz-Schüpke S, Byrne RA, Sibbing D, Hoppmann P, Schneider S, Fusaro M, Ott I, Kristensen SD, Ibrahim T, Massberg S, Schunkert H, Laugwitz KL, Kastrati A, Sarafoff N.

J Am Coll Cardiol. 2015 Apr 28;65(16):1619-29. doi: 10.1016/j.jacc.2015.02.050.

PMID:
25908066
17.

Thienopyridine use after coronary stenting in low income patients enrolled in Medicare part D receiving maintenance dialysis.

[No authors listed]

J Am Heart Assoc. 2015 Apr 23;4(4). pii: e000634. doi: 10.1161/JAHA.115.000634. No abstract available.

18.

Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials.

Cassese S, Byrne RA, Ndrepepa G, Schunkert H, Fusaro M, Kastrati A.

Clin Res Cardiol. 2015 Apr 23. [Epub ahead of print]

PMID:
25903112
19.

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.

Navarese EP, Andreotti F, Schulze V, Kołodziejczak M, Buffon A, Brouwer M, Costa F, Kowalewski M, Parati G, Lip GY, Kelm M, Valgimigli M.

BMJ. 2015 Apr 16;350:h1618. doi: 10.1136/bmj.h1618.

20.

Influences of hyperlipidemia history on stroke outcome; a retrospective cohort study based on the Kyoto Stroke Registry.

Shigematsu K, Watanabe Y, Nakano H; Kyoto Stroke Registry Committee.

BMC Neurol. 2015 Mar 25;15:44. doi: 10.1186/s12883-015-0297-1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk